Clinical Trial Update: A Study to Assess Deucravacitinib Safety in Pregnancy

View source ↗

Summary

This clinical trial update describes an ongoing study to assess the safety of deucravacitinib in pregnant participants with psoriasis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• Sotyktu (Deucravacitinib)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Psoriasis (PsO) | Status: RECRUITING